Skip to content


  • Original
  • Open Access

Botulinum toxin type-A therapy in cluster headache: an open study

  • 1Email author,
  • 1,
  • 1,
  • 1 and
  • 1
The Journal of Headache and PainOfficial Journal of the European Headache Federation20078:400

  • Received: 25 May 2007
  • Accepted: 24 July 2007
  • Published:


The objective of this open single-centre study was to evaluate the efficacy and tolerability of botulinum toxin type-A (BTX-A) as add-on in the prophylactic treatment of cluster headache (CH). Twelve male patients with episodic (n=3) or chronic (n=9) CH, unresponsive to common prophylactic medications, were treated with a cumulative dose of 50 International Units (IU) BTX-A according to a standardised injection scheme into the ipsilateral pericranial muscles. One patient with chronic CH experienced a total cessation of attacks and in 2 patients attack intensity and frequency improved. In another patient with chronic CH typical attacks were not influenced, but an ipsilateral continuous occipital headache significantly improved. Patients with episodic CH did not benefit from BTX-A treatment. Tolerability was excellent. These findings provide evidence that BTX-A may be beneficial as an add-on prophylactic therapy for a limited number of patients with chronic CH.


  • Cluster headache
  • Botulinum toxin-A
  • Headache/drug therapy
  • Treatment outcome


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.